Impel NeuroPharma, Inc.

Impel NeuroPharma, Inc.

Impel NeuroPharma, Inc.

Overview
Date Founded

2008

Headquarters

867 Southwest Shoremont Avenue,Normandy Park, WA 98166

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Medical Products & Equipment
Shipping & Delivery
Hospitals & Patient Services
Holding Companies

Company Description

Impel NeuroPharma, Inc. operates as clinical stage biotechnology firm that develops medical devices. It offers intranasal drug treatments for central nervous system (CNS) disorders. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.

Contact Data
Trying to get in touch with decision makers at Impel NeuroPharma, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Co-Founder

President & Chief Executive Officer

Chief Financial Officer

Director of R&D

Senior Vice President, Regulatory Affairs

Vice President of Medical Affairs-Migraine Franchise

Chief Business Officer

Vice President of Marketing

Project Manager

Board of Directors

President & Chief Executive Officer at Impel NeuroPharma, Inc.

Senior Vice President, Corporate Controller & Chief Accounting Officer at Gilead Sciences, Inc.

Co-Founder at Impel NeuroPharma, Inc.

Former President, Chief Executive Officer & Director at MAP Pharmaceuticals, Inc.

Professional at KKR PRA Investors LP

Executive Chairman at Pearl Therapeutics, Inc.

Partner at Norwest Venture Partners

Managing Partner at venBio Partners LLC

Venture Partner at Vivo Capital LLC

Paths to Impel NeuroPharma, Inc.
Potential Connections via
Relationship Science
You
Impel NeuroPharma, Inc.
Recent Transactions
Details Hidden

Impel NeuroPharma, Inc. raised money in a private placement transaction

Details Hidden

Impel NeuroPharma, Inc. raised money in a private placement transaction

Details Hidden

Impel NeuroPharma, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onImpel NeuroPharma, Inc. raised money in a private placement transaction

Investment Advisor

Advised onImpel NeuroPharma, Inc. raised money in a private placement transaction

Advisors & Consultants
Publicist

Co-Founder at Elixir Health Public Relations

Investors
Details Hidden

Norwest Venture Partners (NVP) invest in companies located in the U.S, India, and Israel . The firm focuses on cloud & IT, internet & consumer, services, healthcare, technology, information services, business services, financial services and consumer product. They provide financing for seed to late stage transactions. Their investment size ranges from $10 to $15 million, whereas growth equity investment size ranges from $10 to $100million.The firm often the lead investor and acquires minority & controlling interests and also considers co-investments. In some cases, they are the sole venture investor, or they may join with other venture capital firms, corporate partners and founding investors.

Details Hidden

Kohlberg Kravis Roberts & Co. LP (KKR) is a active manager which invests in companies located in across the globe. The firm invests in broad range of sectors. It provides financing for traditional management buyouts, build-ups and growth capital requirements in both private and public companies. It also makes minority investments.

Details Hidden

venBio Partners LLC invests in public and private life science companies located in the US. The firm provides financing for early and later stage capital requirements and also acts as lead investor.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Impel NeuroPharma, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Impel NeuroPharma, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Impel NeuroPharma, Inc..